Skip to content
10-Q

Quarterly Report

GREEN VISION BIOTECHNOLOGY CORP.

0001640334-21-002397

← back to feed
Filed
Sep 28, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Sep 27, 2021 160.79M sh
Current Liabilities Q2 2021 · Jun 30, 2021 $10.75M
Current Liabilities Q2 2021 · Dec 31, 2020 $10.45M
Total Liabilities Q2 2021 · Jun 30, 2021 $10.75M
Total Liabilities Q2 2021 · Dec 31, 2020 $10.45M
Current Assets Q2 2021 · Jun 30, 2021 $164.28K
Current Assets Q2 2021 · Dec 31, 2020 $50.92K
Total Assets Q2 2021 · Jun 30, 2021 $3.1M
Total Assets Q2 2021 · Dec 31, 2020 $3.04M
Net Income Q2 2021 · Jun 30, 2021 −$231.72K
Net Income Q2 2021 · Jun 30, 2020 −$33.68K
Net Income Q2 2021 · Jun 30, 2020 −$53.51K
Net Income Q2 2021 · Mar 31, 2020 −$23.39K
Shares Diluted Q2 2021 · Jun 30, 2020 160.79M sh
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$31.7K
Cash And Equivalents Q2 2021 · Jun 30, 2020 $82.29K
Cash And Equivalents Q2 2021 · Dec 31, 2019 $61.75K
Stockholders Equity Q2 2021 · Jun 30, 2020 −$6.98M
Stockholders Equity Q2 2021 · Mar 31, 2020 −$6.95M
Stockholders Equity Q2 2021 · Dec 31, 2019 −$6.91M
Operating Income Q2 2021 · Jun 30, 2020 −$90.38K
Operating Income Q2 2021 · Jun 30, 2020 −$186.6K
Gross Profit Q2 2021 · Jun 30, 2020 $5.24K
Gross Profit Q2 2021 · Jun 30, 2020 −$10.16K
Revenue Q2 2021 · Jun 30, 2020 $27.09K
Revenue Q2 2021 · Jun 30, 2020 $66.87K